These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24131912)

  • 1. Concomitant alopecia areata and hypertrichosis after infliximab therapy: rara avis.
    Akarsu S; Tok F; Tekin L
    Acta Reumatol Port; 2013; 38(1):49-50. PubMed ID: 24131912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasiform eruption associated with alopecia areata during infliximab therapy.
    Nakagomi D; Harada K; Yagasaki A; Kawamura T; Shibagaki N; Shimada S
    Clin Exp Dermatol; 2009 Dec; 34(8):923-4. PubMed ID: 19438542
    [No Abstract]   [Full Text] [Related]  

  • 4. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
    Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
    Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
    Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
    Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of alopecia areata after biological therapy with TNF-alpha Blockers: description of a case and review of the literature.
    Hernández MV; Nogués S; Ruiz-Esquide V; Alsina M; Cañete JD; Sanmartí R
    Clin Exp Rheumatol; 2009; 27(5):892-3. PubMed ID: 19917182
    [No Abstract]   [Full Text] [Related]  

  • 7. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
    Fabre C; Dereure O
    Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487
    [No Abstract]   [Full Text] [Related]  

  • 8. Alopecia areata following adalimumab.
    Kirshen C; Kanigsberg N
    J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: A case of serendipity or zemblanity?
    Sacchelli L; Magnano M; Patrizi A; Bardazzi F
    Dermatol Ther; 2019 May; 32(3):e12894. PubMed ID: 30963671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata in a patient receiving infliximab.
    Ormaechea-Pérez N; López-Pestaña A; Muñagorri-Santos AI; Moreno AJ; Tuneu-Valls A
    Indian J Dermatol Venereol Leprol; 2013; 79(4):529-31. PubMed ID: 23760327
    [No Abstract]   [Full Text] [Related]  

  • 11. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab-induced crusted pustular eruption with patchy alopecia.
    Fischer R; Blackmon J; Rajpara A
    Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata developing during ustekinumab therapy: report of two cases.
    Tauber M; Beneton N; Reygagne P; Bachelez H; Viguier M
    Eur J Dermatol; 2013; 23(6):912-3. PubMed ID: 24334218
    [No Abstract]   [Full Text] [Related]  

  • 14. Alopecia secondary to anti-tumor necrosis factor-alpha therapy.
    Ribeiro LB; Rego JC; Estrada BD; Bastos PR; Piñeiro Maceira JM; Sodré CT
    An Bras Dermatol; 2015; 90(2):232-5. PubMed ID: 25830994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

  • 16. Alopecia areata during treatment with biologic agents.
    Tosti A; Pazzaglia M; Starace M; Bellavista S; Vincenzi C; Tonelli G
    Arch Dermatol; 2006 Dec; 142(12):1653-4. PubMed ID: 17179002
    [No Abstract]   [Full Text] [Related]  

  • 17. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
    Navarro R; Daudén E; Gallo E; Santiago Sánchez-Mateos D; García-Diez A
    Skin Pharmacol Physiol; 2012; 25(2):107-10. PubMed ID: 22301842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
    Ettefagh L; Nedorost S; Mirmirani P
    Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
    [No Abstract]   [Full Text] [Related]  

  • 19. Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus.
    Worsnop F; Wee J; Natkunarajah J; Moosa Y; Marsden R
    Clin Exp Dermatol; 2012 Dec; 37(8):879-81. PubMed ID: 22548502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A child with generalized hypertrichosis due to secondary topical minoxidil exposure.
    Maltoni G; Cedirian S; Scozzarella A; Bernardini L; Piraccini BM; Starace M
    Pediatr Dermatol; 2023; 40(4):753-754. PubMed ID: 37042338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.